These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4405656

  • 1. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
    Andén NE.
    J Pharm Pharmacol; 1972 Nov; 24(11):905-6. PubMed ID: 4405656
    [No Abstract] [Full Text] [Related]

  • 2. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.
    Andén NE, Stock G.
    J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695
    [No Abstract] [Full Text] [Related]

  • 3. Drug-induced changes of dopamine turnover in striatum and limbic system of the rat.
    Bartholini G, Keller HH, Pletscher A.
    J Pharm Pharmacol; 1975 Jun; 27(6):439-42. PubMed ID: 237095
    [No Abstract] [Full Text] [Related]

  • 4. Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system.
    Andén NE.
    J Pharm Pharmacol; 1974 Sep; 26(9):738-40. PubMed ID: 4155755
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H, Baggiolini M, Burki HR, Lauener H, Ruch W, Stille G.
    Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC.
    Experientia; 1980 Sep 15; 36(9):1092-4. PubMed ID: 6448165
    [Abstract] [Full Text] [Related]

  • 13. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Sep 15; 72(4):595-603. PubMed ID: 4341763
    [No Abstract] [Full Text] [Related]

  • 14. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Sep 15; 54():233-46. PubMed ID: 769114
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K, Nyström M, Tovi M, Smith R, Ogren SO.
    J Psychiatr Res; 1974 Sep 15; 11():151-61. PubMed ID: 4156786
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA.
    Am J Psychiatry; 1996 Jan 15; 153(1):41-9. PubMed ID: 8540590
    [Abstract] [Full Text] [Related]

  • 19. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A, Kostowski W.
    Psychiatr Pol; 1984 Jan 15; 18(1):39-47. PubMed ID: 6146150
    [No Abstract] [Full Text] [Related]

  • 20. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY, Stahl SM.
    Schizophr Bull; 1976 Jan 15; 2(1):19-76. PubMed ID: 779020
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.